Drugs / Captafer®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02774057 | Mar 2016 → Jul 2017 | inflammatory bowel disease, iron deficiency anemia | American University of Beirut Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Captafer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02774057 ↗ |
| Route | Oral | “Captafer is a new iron-free oral preparation” NCT02774057 ↗ |